Publication: Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: Insights from the 2019 annual APMEN Vivax Working Group meeting
Issued Date
2021-05-01
Resource Type
ISSN
20502680
DOI
Other identifier(s)
2-s2.0-85099228780
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asia and the Pacific Policy Studies. Vol.8, No.2 (2021), 208-242
Suggested Citation
Varunika Sonani Hapuwatte Ruwanpura, Spike Nowak, Emily Gerth-Guyette, Minerva Theodora, Lek Dysoley, Mebratom Haile, Koen Peeters Grietens, Ric Norman Price, Caroline Anita Lynch, Kamala Thriemer Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: Insights from the 2019 annual APMEN Vivax Working Group meeting. Asia and the Pacific Policy Studies. Vol.8, No.2 (2021), 208-242. doi:10.1002/app5.314 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/76446
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Further evidence needed to change policy for the safe and effective radical cure of vivax malaria: Insights from the 2019 annual APMEN Vivax Working Group meeting
Other Contributor(s)
Faculty of Tropical Medicine, Mahidol University
London School of Hygiene & Tropical Medicine
PATH Seattle
Prins Leopold Instituut voor Tropische Geneeskunde
Menzies School of Health Research
Nagasaki University
Nuffield Department of Medicine
National Centre for Parasitology
The National Institute of Public Health
Medicines for Malaria Venture
National Malaria Control Program of Indonesia
Federal Ministry of Health
London School of Hygiene & Tropical Medicine
PATH Seattle
Prins Leopold Instituut voor Tropische Geneeskunde
Menzies School of Health Research
Nagasaki University
Nuffield Department of Medicine
National Centre for Parasitology
The National Institute of Public Health
Medicines for Malaria Venture
National Malaria Control Program of Indonesia
Federal Ministry of Health
Abstract
New diagnostics and treatment options for the radical cure of Plasmodium vivax malaria are now available. At the 2019 annual meeting of the Vivax Working Group of the Asia Pacific Malaria Elimination Network, participants took part in a roundtable discussion to identify further evidence required to introduce these new tools into policy and practice. Key gaps identified were accuracy and reliability of glucose-6-phosphate-dehydrogenase deficiency tests, health system capacity, and feasibility and cost effectiveness of novel treatment strategies in routine clinical practice. As expected, there were differences in the priorities between country partners and researcher partners. To achieve the 2030 target for the regional elimination of malaria, evidence to address these issues should be generated as a matter of priority. Review of global guidelines alongside locally generated data will help to ensure the timely revision and optimisation of national treatment guidelines that will be vital to meet regional elimination goals.